Advertisement
Screener

Gene Biotherapeutics, Inc. Accrued Liabilities, Current

Gene Biotherapeutics, Inc. Accrued Liabilities, Current

Gene Biotherapeutics, Inc. had Accrued Liabilities, Current of $3.13 million as of 2020-12-31, per its 10-K/A filed 2022-04-14.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current

us-gaap:AccruedLiabilitiesCurrent · last filed 2022-04-14

  • 2020-12-31: Accrued Liabilities, Current $3.13M.
  • 2020-09-30: Accrued Liabilities, Current $3.06M.
  • 2020-06-30: Accrued Liabilities, Current $2.98M.
  • 2020-03-31: Accrued Liabilities, Current $2.89M.
Period endAccrued Liabilities, CurrentAccrued Liabilities, Current as first filed
2020-12-31$3.13M
10-K/A · filed 2022-04-14
2020-09-30$3.06M
10-Q · filed 2021-10-27
2020-06-30$2.98M
10-Q · filed 2021-09-17
2020-03-31$2.89M
10-Q · filed 2021-09-03
2019-12-31$2.80M
10-K/A · filed 2022-04-14
2018-12-31$2.86M
10-K · filed 2021-04-23
2017-12-31$2.24M
10-K · filed 2021-04-23
2017-03-31$1.66M
10-Q · filed 2017-07-28
2016-12-31$1.67M
10-K · filed 2017-07-28
2016-09-30$1.71M
10-Q · filed 2017-03-21
2016-06-30$1.58M
10-Q · filed 2017-03-06
2016-03-31$1.27M
10-Q · filed 2017-03-01
2015-12-31$1.09M
10-K · filed 2017-07-28
2015-09-30$967.92K
10-Q · filed 2016-10-27
2015-06-30$809.33K
10-Q · filed 2016-08-29
2015-03-31$668.23K
10-Q · filed 2015-06-18
2014-12-31$535.25K
10-K · filed 2016-12-29
2014-09-30$599.35K
10-Q · filed 2014-11-19
2014-06-30$667.43K
10-Q · filed 2014-08-12
2014-03-31$739.64K
10-Q · filed 2014-05-15
2013-12-31$611.01K
10-K · filed 2015-05-22
2013-09-30$364.55K
10-Q · filed 2013-11-19
2013-06-30$492.88K
10-Q · filed 2013-08-14
2013-03-31$551.78K
10-Q · filed 2013-05-15
2012-12-31$376.51K
10-K · filed 2014-04-15
$614.86K
10-K · filed 2013-04-05
2012-09-30$736.75K
10-Q · filed 2012-11-14
2012-06-30$418.45K
10-Q · filed 2012-08-14
2012-03-31$500.93K
10-Q · filed 2012-05-15
2011-12-31$464.89K
10-K · filed 2013-04-05
2011-09-30$749.51K
10-Q · filed 2011-11-14
2011-06-30$759.98K
10-Q · filed 2011-08-15
2010-12-31$748.11K
10-K · filed 2012-03-30